Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | 2.83%1.93B | 11.73%1.88B | 9.56%1.68B | 1.54B |
| Revenue from customers | -4.23%3.89B | 13.56%4.06B | 4.69%3.58B | --3.42B |
| Other cash income from operating activities | 10.32%-1.96B | -15.19%-2.18B | -0.71%-1.89B | ---1.88B |
| Cash paid | 3.01%-1.1B | -15.75%-1.13B | -30.57%-979.4M | -750.1M |
| Payments to suppliers for goods and services | 3.01%-1.1B | -15.75%-1.13B | -30.57%-979.4M | ---750.1M |
| Direct interest paid | -0.65%-124.2M | -3.44%-123.4M | -1,956.90%-119.3M | ---5.8M |
| Direct interest received | -38.98%10.8M | 742.86%17.7M | 2,000.00%2.1M | --100K |
| Direct tax refund paid | -20.63%-180.1M | -14.06%-149.3M | 16.57%-130.9M | ---156.9M |
| Operating cash flow | 9.92%541.7M | 7.95%492.8M | -26.89%456.5M | --624.4M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -9.59%-96M | 27.72%-87.6M | -90.87%-121.2M | -63.5M |
| Net PPE purchase and sale | -4.53%-71.6M | 13.94%-68.5M | -226.23%-79.6M | ---24.4M |
| Net investment purchase and sale | ---- | ---- | 28.03%-41.6M | ---57.8M |
| Net other investing changes | -27.75%-24.4M | ---19.1M | ---- | --18.7M |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -9.59%-96M | 27.72%-87.6M | -90.87%-121.2M | ---63.5M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -5.31%-414.7M | -81.47%-393.8M | 52.47%-217M | -456.6M |
| Net issuance payments of debt | 114.29%10M | ---70M | ---- | ---455M |
| Net common stock issuance | -69.72%-74M | -323.30%-43.6M | ---10.3M | ---- |
| Cash dividends paid | -25.93%-340M | -36.99%-270M | ---197.1M | ---- |
| Net other financing activities | 47.55%-10.7M | -6.25%-20.4M | -500.00%-19.2M | ---3.2M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -5.31%-414.7M | -81.47%-393.8M | 52.47%-217M | ---456.6M |
| Net cash flow | ||||
| Beginning cash position | 2.62%445.9M | 37.41%434.5M | 49.22%316.2M | --211.9M |
| Current changes in cash | 171.93%31M | -90.36%11.4M | 13.42%118.3M | --104.3M |
| End cash Position | 6.95%476.9M | 2.62%445.9M | 37.41%434.5M | --316.2M |
| Free cash from | 10.79%470.1M | 12.58%424.3M | -37.18%376.9M | --600M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |